ID   IGLL1_HUMAN             Reviewed;         213 AA.
AC   P15814; Q0P681;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 1.
DT   28-JUN-2023, entry version 200.
DE   RecName: Full=Immunoglobulin lambda-like polypeptide 1;
DE   AltName: Full=CD179 antigen-like family member B;
DE   AltName: Full=Ig lambda-5;
DE   AltName: Full=Immunoglobulin omega polypeptide;
DE   AltName: Full=Immunoglobulin-related protein 14.1;
DE   AltName: CD_antigen=CD179b;
DE   Flags: Precursor;
GN   Name=IGLL1; Synonyms=IGL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2501791; DOI=10.1073/pnas.86.14.5552;
RA   Hollis G.F., Evans R.J., Stafford-Hollis J.M., Korsmeyer S.J.,
RA   McKearn J.P.;
RT   "Immunoglobulin lambda light-chain-related genes 14.1 and 16.1 are
RT   expressed in pre-B cells and may encode the human immunoglobulin omega
RT   light-chain protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:5552-5556(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lymphoid tissue;
RX   PubMed=1703205; DOI=10.1084/jem.173.2.305;
RA   Evans R.J., Hollis G.F.;
RT   "Genomic structure of the human Ig lambda 1 gene suggests that it may be
RT   expressed as an Ig lambda 14.1-like protein or as a canonical B cell Ig
RT   lambda light chain: implications for Ig lambda gene evolution.";
RL   J. Exp. Med. 173:305-311(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-193, AND TISSUE SPECIFICITY.
RX   PubMed=2128466; DOI=10.1093/intimm/2.3.201;
RA   Schiff C., Bensmana M., Guglielmi P., Milili M., Lefranc M.-P.,
RA   Fougereau M.;
RT   "The immunoglobulin lambda-like gene cluster (14.1, 16.1 and F lambda 1)
RT   contains gene(s) selectively expressed in pre-B cells and is the human
RT   counterpart of the mouse lambda 5 gene.";
RL   Int. Immunol. 2:201-207(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 95-213.
RX   PubMed=3003227; DOI=10.1084/jem.163.2.425;
RA   Chang H., Dmitrovsky E., Hieter P.A., Mitchell K., Leder P., Turoczi L.,
RA   Kirsch I.R., Hollis G.F.;
RT   "Identification of three new Ig lambda-like genes in man.";
RL   J. Exp. Med. 163:425-435(1986).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND VARIANT AGM2 LEU-142.
RX   PubMed=9419212; DOI=10.1084/jem.187.1.71;
RA   Minegishi Y., Coustan-Smith E., Wang Y.H., Cooper M.D., Campana D.,
RA   Conley M.E.;
RT   "Mutations in the human lambda5/14.1 gene result in B cell deficiency and
RT   agammaglobulinemia.";
RL   J. Exp. Med. 187:71-77(1998).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 93-209 IN COMPLEX WITH VPREB1,
RP   SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=17431183; DOI=10.1126/science.1139412;
RA   Bankovich A.J., Raunser S., Juo Z.S., Walz T., Davis M.M., Garcia K.C.;
RT   "Structural insight into pre-B cell receptor function.";
RL   Science 316:291-294(2007).
CC   -!- FUNCTION: Critical for B-cell development.
CC       {ECO:0000269|PubMed:9419212}.
CC   -!- SUBUNIT: Associates non-covalently with VPREB1 (PubMed:17431183).
CC       Interacts with SYNV1/HRD1 (via N-terminus); this interaction leads to
CC       increased IGLL1 ubiquitination and degradation in pre-B cells, possibly
CC       through a lysosomal, not proteasomal, pathway (By similarity).
CC       {ECO:0000250|UniProtKB:P20764, ECO:0000269|PubMed:17431183}.
CC   -!- INTERACTION:
CC       P15814; B3EWG5: FAM25C; NbExp=3; IntAct=EBI-1222221, EBI-14240149;
CC       P15814; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-1222221, EBI-947187;
CC       P15814; Q2GHU2: ECH_0166; Xeno; NbExp=2; IntAct=EBI-1222221, EBI-26585631;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000250|UniProtKB:P20764}. Secreted {ECO:0000269|PubMed:9419212}.
CC       Note=In pre-B cells, localizes predominantly to the endoplasmic
CC       reticulum. {ECO:0000250|UniProtKB:P20764}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P15814-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P15814-2; Sequence=VSP_042748;
CC   -!- TISSUE SPECIFICITY: Expressed only in pre-B-cells and a special B-cell
CC       line (which is surface Ig negative). {ECO:0000269|PubMed:2128466}.
CC   -!- DISEASE: Agammaglobulinemia 2, autosomal recessive (AGM2) [MIM:613500]:
CC       A primary immunodeficiency characterized by profoundly low or absent
CC       serum antibodies and low or absent circulating B cells due to an early
CC       block of B-cell development. Affected individuals develop severe
CC       infections in the first years of life. {ECO:0000269|PubMed:9419212}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- WEB RESOURCE: Name=IGLL1base; Note=IGLL1 mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/IGLL1base/";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=IGLL1;
CC       URL="https://en.wikipedia.org/wiki/IGLL1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M27749; AAA36100.1; -; mRNA.
DR   EMBL; M34513; AAA36096.1; -; Genomic_DNA.
DR   EMBL; M34511; AAA36096.1; JOINED; Genomic_DNA.
DR   EMBL; M34512; AAA36096.1; JOINED; Genomic_DNA.
DR   EMBL; AP000345; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC030239; AAH30239.2; -; mRNA.
DR   EMBL; BC012293; AAH12293.1; -; mRNA.
DR   EMBL; X03528; CAA27229.1; -; Genomic_DNA.
DR   EMBL; X03530; CAA27231.1; -; Genomic_DNA.
DR   CCDS; CCDS13809.1; -. [P15814-1]
DR   CCDS; CCDS13810.1; -. [P15814-2]
DR   PIR; A33911; A33911.
DR   RefSeq; NP_064455.1; NM_020070.3. [P15814-1]
DR   RefSeq; NP_690594.1; NM_152855.2. [P15814-2]
DR   PDB; 2H32; X-ray; 2.70 A; B=93-213.
DR   PDB; 2H3N; X-ray; 2.30 A; B/D=94-209.
DR   PDB; 2LKQ; NMR; -; A=59-82.
DR   PDBsum; 2H32; -.
DR   PDBsum; 2H3N; -.
DR   PDBsum; 2LKQ; -.
DR   AlphaFoldDB; P15814; -.
DR   BMRB; P15814; -.
DR   SMR; P15814; -.
DR   BioGRID; 109759; 8.
DR   CORUM; P15814; -.
DR   IntAct; P15814; 9.
DR   MINT; P15814; -.
DR   STRING; 9606.ENSP00000329312; -.
DR   DrugBank; DB09130; Copper.
DR   GlyCosmos; P15814; 2 sites, 2 glycans.
DR   GlyGen; P15814; 2 sites, 2 O-linked glycans (2 sites).
DR   iPTMnet; P15814; -.
DR   PhosphoSitePlus; P15814; -.
DR   BioMuta; IGLL1; -.
DR   DMDM; 123944; -.
DR   jPOST; P15814; -.
DR   MassIVE; P15814; -.
DR   MaxQB; P15814; -.
DR   PaxDb; P15814; -.
DR   PeptideAtlas; P15814; -.
DR   ProteomicsDB; 53223; -. [P15814-1]
DR   ProteomicsDB; 53224; -. [P15814-2]
DR   Antibodypedia; 9342; 321 antibodies from 30 providers.
DR   DNASU; 3543; -.
DR   Ensembl; ENST00000249053.3; ENSP00000249053.3; ENSG00000128322.7. [P15814-2]
DR   Ensembl; ENST00000330377.3; ENSP00000329312.2; ENSG00000128322.7. [P15814-1]
DR   GeneID; 3543; -.
DR   KEGG; hsa:3543; -.
DR   MANE-Select; ENST00000330377.3; ENSP00000329312.2; NM_020070.4; NP_064455.1.
DR   UCSC; uc002zxd.4; human. [P15814-1]
DR   AGR; HGNC:5870; -.
DR   CTD; 3543; -.
DR   DisGeNET; 3543; -.
DR   GeneCards; IGLL1; -.
DR   HGNC; HGNC:5870; IGLL1.
DR   HPA; ENSG00000128322; Group enriched (bone marrow, testis).
DR   MalaCards; IGLL1; -.
DR   MIM; 146770; gene.
DR   MIM; 613500; phenotype.
DR   neXtProt; NX_P15814; -.
DR   OpenTargets; ENSG00000128322; -.
DR   Orphanet; 33110; Autosomal agammaglobulinemia.
DR   PharmGKB; PA29756; -.
DR   VEuPathDB; HostDB:ENSG00000128322; -.
DR   eggNOG; ENOG502SPNC; Eukaryota.
DR   GeneTree; ENSGT00940000153307; -.
DR   HOGENOM; CLU_2526772_0_0_1; -.
DR   InParanoid; P15814; -.
DR   OMA; WAGPRCW; -.
DR   OrthoDB; 3972376at2759; -.
DR   PhylomeDB; P15814; -.
DR   TreeFam; TF335549; -.
DR   PathwayCommons; P15814; -.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   SignaLink; P15814; -.
DR   BioGRID-ORCS; 3543; 29 hits in 1149 CRISPR screens.
DR   ChiTaRS; IGLL1; human.
DR   EvolutionaryTrace; P15814; -.
DR   GeneWiki; IGLL1; -.
DR   GenomeRNAi; 3543; -.
DR   Pharos; P15814; Tbio.
DR   PRO; PR:P15814; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P15814; protein.
DR   Bgee; ENSG00000128322; Expressed in bone marrow and 101 other tissues.
DR   ExpressionAtlas; P15814; baseline and differential.
DR   Genevisible; P15814; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   CDD; cd07699; IgC1_L; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   PANTHER; PTHR19944:SF98; IG-LIKE DOMAIN-CONTAINING PROTEIN; 1.
DR   PANTHER; PTHR19944; MHC CLASS II-RELATED; 1.
DR   Pfam; PF07654; C1-set; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Disease variant; Disulfide bond;
KW   Endoplasmic reticulum; Immunoglobulin domain; Reference proteome; Secreted;
KW   Signal.
FT   SIGNAL          1..37
FT                   /evidence="ECO:0000255"
FT   CHAIN           38..213
FT                   /note="Immunoglobulin lambda-like polypeptide 1"
FT                   /id="PRO_0000014777"
FT   DOMAIN          114..208
FT                   /note="Ig-like C1-type"
FT   REGION          97..108
FT                   /note="J region"
FT                   /evidence="ECO:0000250"
FT   REGION          109..213
FT                   /note="C region"
FT                   /evidence="ECO:0000250"
FT   DISULFID        135..194
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:17431183"
FT   DISULFID        212
FT                   /note="Interchain (with a heavy chain)"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         70..213
FT                   /note="FLLQRGSWTGPRCWPRGFQSKHNSVTHVFGSGTQLTVLSQPKATPSVTLFPP
FT                   SSEELQANKATLVCLMNDFYPGILTVTWKADGTPITQGVEMTTPSKQSNNKYAASSYLS
FT                   LTPEQWRSRRSYSCQVMHEGSTVEKTVAPAECS -> SAQGHPLGHSVPAVL (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042748"
FT   VARIANT         142
FT                   /note="P -> L (in AGM2; dbSNP:rs1064422)"
FT                   /evidence="ECO:0000269|PubMed:9419212"
FT                   /id="VAR_034869"
FT   VARIANT         189
FT                   /note="R -> H (in dbSNP:rs8138122)"
FT                   /id="VAR_059392"
FT   TURN            61..65
FT                   /evidence="ECO:0007829|PDB:2LKQ"
FT   HELIX           66..70
FT                   /evidence="ECO:0007829|PDB:2LKQ"
FT   HELIX           72..75
FT                   /evidence="ECO:0007829|PDB:2LKQ"
FT   STRAND          102..108
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   STRAND          115..119
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   HELIX           123..126
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   TURN            127..129
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   STRAND          131..143
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   STRAND          146..151
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   STRAND          158..162
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   STRAND          173..181
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   HELIX           183..188
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   STRAND          192..198
FT                   /evidence="ECO:0007829|PDB:2H3N"
FT   STRAND          201..207
FT                   /evidence="ECO:0007829|PDB:2H3N"
SQ   SEQUENCE   213 AA;  22963 MW;  9133A7742B943C79 CRC64;
     MRPGTGQGGL EAPGEPGPNL RQRWPLLLLG LAVVTHGLLR PTAASQSRAL GPGAPGGSSR
     SSLRSRWGRF LLQRGSWTGP RCWPRGFQSK HNSVTHVFGS GTQLTVLSQP KATPSVTLFP
     PSSEELQANK ATLVCLMNDF YPGILTVTWK ADGTPITQGV EMTTPSKQSN NKYAASSYLS
     LTPEQWRSRR SYSCQVMHEG STVEKTVAPA ECS
//
